Dong Dai Selected Research

HS 3 (HS-3)

1/2021

Epidemiology of stroke in urban northeast China: A population-based study 2018-2019.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong Dai Research Topics

Disease

9	Neoplasms (Cancer) 03/2022 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 02/2016
4	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2014
3	Liver Neoplasms (Liver Cancer) 01/2021 - 06/2003
3	Adenocarcinoma of Lung 01/2021 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 12/2013
2	Lymphoma (Lymphomas) 03/2022 - 01/2014
2	Lymphatic Metastasis 06/2021 - 01/2017
2	Ischemic Stroke 01/2021 - 10/2020
2	Lung Neoplasms (Lung Cancer) 12/2017 - 01/2017
1	Psoriatic Arthritis 03/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Stroke (Strokes) 01/2021
1	Ankylosing Spondylitis 01/2021
1	Dyslipidemias (Dyslipidemia) 11/2020
1	Insulin Resistance 10/2020
1	Body Weight (Weight, Body) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Calcinosis 06/2019
1	Carcinoid Tumor (Carcinoid) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Paraganglioma (Paragangliomas) 01/2019
1	Adenocarcinoma 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2017
1	Ovarian Neoplasms (Ovarian Cancer) 08/2017
1	Pathologic Processes 08/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2017
1	Carcinoma (Carcinomatosis) 11/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 05/2015

Drug/Important Bio-Agent (IBA)

8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2022 - 01/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 02/2016
4	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 04/2016
2	Biological ProductsIBA 03/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2019
2	Carcinoembryonic AntigenIBA 09/2017 - 01/2017
2	LigandsIBA 08/2003 - 06/2003
2	PPAR gammaIBA 08/2003 - 06/2003
1	ibrutinibIBA 03/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	HS 3 (HS-3)IBA 01/2021
1	CholesterolIBA 11/2020
1	LipidsIBA 11/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	CytokinesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Sodium Fluoride (Ossin)FDA Link 06/2019
1	FluorineIBA 06/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	gallium Ga 68 dotatateIBA 01/2019
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 08/2017
1	Fluorine-18IBA 02/2017
1	Metalloproteases (Metalloproteinases)IBA 04/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2016
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 04/2016
1	Protein Isoforms (Isoforms)IBA 04/2016
1	Tyrosine Kinase InhibitorsIBA 02/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	pyrazolanthroneIBA 05/2015
1	metuximabIBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2003
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2003
1	Troglitazone (Rezulin)FDA Link 06/2003

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2014
1	Length of Stay 01/2021
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 12/2017
1	Brachytherapy 08/2017
1	Drug Therapy (Chemotherapy) 02/2017
1	Adjuvant Chemotherapy 01/2017
1	Radiofrequency Ablation 10/2014
1	Chemoprevention 08/2003